Transmodulation of Epidermal Growth Factor Receptor Function by Cyclic AMP-dependent Protein Kinase

Ann Barbier, Helen Poppleton, Yinges Yigzaw, Jason B. Mullenix, Gregory J. Wiepz, Paul J. Bertics, Tarun B. Patel

Journal of Biological Chemistry · 1999 · 54 citations · 37 references

DOIFull text

Open access

Concepts

Abstract

Binding of epidermal growth factor (EGF) to its receptor (EGFR) augments the tyrosine kinase activity of the receptor and autophosphorylation. Exposure of some tissues and cells to EGF also stimulates adenylyl cyclase activity and results in an increase in cyclic AMP (cAMP) levels. Because cAMP activates the cAMP-dependent protein kinase A (PKA), we investigated the effect of PKA on the EGFR. The purified catalytic subunit of PKA (PKAc) stoichiometrically phosphorylated the purified full-length wild type (WT) and kinase negative (K721M) forms of the EGFR. PKAc phosphorylated both WT-EGFR as well as a mutant truncated form of EGFR (Δ1022–1186) exclusively on serine residues. Moreover, PKAc also phosphorylated the cytosolic domain of the EGFR (EGFRKD). Phosphorylation of the purified WT as well as EGFRΔ1022–1186 and EGFRKD was accompanied by decreased autophosphorylation and diminished tyrosine kinase activity. Pretreatment of REF-52 cells with the nonhydrolyzable cAMP analog, 8-(4-chlorophenylthio)-cAMP, decreased EGF-induced tyrosine phosphorylation of cellular proteins as well as activation of the WT-EGFR. Similar effects were also observed in B82L cells transfected to express the Δ1022–1186 form of EGFR. Furthermore, activation of PKAc in intact cells resulted in serine phosphorylation of the EGFR. The decreased phosphorylation of cellular proteins and diminished activation of the EGFR in cells treated with the cAMP analog was not the result of altered binding of EGF to its receptors or changes in receptor internalization. Therefore, we conclude that PKA phosphorylates the EGFR on Ser residues and decreases its tyrosine kinase activity and signal transduction both in vitro andin vivo. Binding of epidermal growth factor (EGF) to its receptor (EGFR) augments the tyrosine kinase activity of the receptor and autophosphorylation. Exposure of some tissues and cells to EGF also stimulates adenylyl cyclase activity and results in an increase in cyclic AMP (cAMP) levels. Because cAMP activates the cAMP-dependent protein kinase A (PKA), we investigated the effect of PKA on the EGFR. The purified catalytic subunit of PKA (PKAc) stoichiometrically phosphorylated the purified full-length wild type (WT) and kinase negative (K721M) forms of the EGFR. PKAc phosphorylated both WT-EGFR as well as a mutant truncated form of EGFR (Δ1022–1186) exclusively on serine residues. Moreover, PKAc also phosphorylated the cytosolic domain of the EGFR (EGFRKD). Phosphorylation of the purified WT as well as EGFRΔ1022–1186 and EGFRKD was accompanied by decreased autophosphorylation and diminished tyrosine kinase activity. Pretreatment of REF-52 cells with the nonhydrolyzable cAMP analog, 8-(4-chlorophenylthio)-cAMP, decreased EGF-induced tyrosine phosphorylation of cellular proteins as well as activation of the WT-EGFR. Similar effects were also observed in B82L cells transfected to express the Δ1022–1186 form of EGFR. Furthermore, activation of PKAc in intact cells resulted in serine phosphorylation of the EGFR. The decreased phosphorylation of cellular proteins and diminished activation of the EGFR in cells treated with the cAMP analog was not the result of altered binding of EGF to its receptors or changes in receptor internalization. Therefore, we conclude that PKA phosphorylates the EGFR on Ser residues and decreases its tyrosine kinase activity and signal transduction both in vitro andin vivo. Epidermal Growth Factor (EGF) 1The abbreviations used are: EGF, epidermal growth factor; EGFR, EGF receptor; WT, wild type; EGFRΔ1022–1186, EGFR in which all amino acids after 1021 are deleted; EGFRKD, cytosolic region (amino acids 644–1186) of the EGFR in which the extracellular and transmembrane domains are deleted; PKA, cAMP-dependent protein kinase; PKAc, catalytic subunit of PKA; MAPK, mitogen-activated protein kinase; PKC, protein kinase C; 8-CPT-cAMP, 8-(4-chlorophenylthio)-cAMP; MES, 4-morpholineethanesulfonic acid; PAGE, polyacrylamide gel electrophoresis is responsible for a variety of biological effects ranging from mitogenesis (1Carpenter G. Cohen S. J. Biol. Chem. 1990; 265: 7709-7712Abstract Full Text PDF PubMed Google Scholar) to influences on glucose metabolism (2Rashed S.M. Patel T.B. Eur. J. Biochem. 1991; 197: 805-813Crossref PubMed Scopus (19) Google Scholar). Upon binding of EGF to its receptor, the epidermal growth factor receptor (EGFR) undergoes dimerization and displays tyrosine kinase activity. This leads to autophosphorylation of the EGFR as well as phosphorylation of intracellular substrates (3Ullrich A. Schlessinger J. Cell. 1990; 61: 203-212Abstract Full Text PDF PubMed Scopus (4619) Google Scholar). In addition, we have shown that, in the heart, EGF increases contractility and heart rate by augmenting cAMP accumulation (4Nair B.G. Rashed H.M. Patel T.B. Growth Factors. 1993; 8: 41-48Crossref PubMed Scopus (34) Google Scholar), a result of stimulation of adenylyl cyclase activity via activation of Gsα (4Nair B.G. Rashed H.M. Patel T.B. Growth Factors. 1993; 8: 41-48Crossref PubMed Scopus (34) Google Scholar, 5Nair B.G. Rashed H.M. Patel T.B. Biochem. J. 1989; 264: 563-571Crossref PubMed Scopus (48) Google Scholar, 6Nair B.G. Parikh B. Milligan G. Patel T.B. J. Biol. Chem. 1990; 265: 21317-21322Abstract Full Text PDF PubMed Google Scholar). Additionally, we have also demonstrated that EGF-elicited stimulation of adenylyl cyclase activity requires the tyrosine kinase activity of the EGFR and may involve phosphorylation of Gsα (7Nair B.G. Patel T.B. Biochem. Pharmacol. 1993; 46: 1239-1245Crossref PubMed Scopus (35) Google Scholar, 8Poppleton H. Sun H. Fulgham D. Bertics P. Patel T.B. J. Biol. Chem. 1996; 271: 6947-6951Abstract Full Text Full Text PDF PubMed Scopus (76) Google Scholar). The cyclic AMP formed in response to EGF can activate the heterotetrameric cAMP-dependent protein kinase A (PKA) by binding to its two regulatory subunits, thereby dissociating them from the catalytic subunits (9Walsh D.A. Van Patten S.M. FASEB J. 1994; 8: 1227-1236Crossref PubMed Scopus (216) Google Scholar). The catalytic subunit of PKA (PKAc) can then phosphorylate a variety of intracellular proteins (9Walsh D.A. Van Patten S.M. FASEB J. 1994; 8: 1227-1236Crossref PubMed Scopus (216) Google Scholar). The EGFR is a 170-kDa glycoprotein with a single transmembrane domain. Its intracellular domain is susceptible to phosphorylation on various residues. Thus, the five autophosphorylation sites in the cytosolic domain of EGFR are located at tyrosine residues 992, 1068, 1086, 1148, and 1173 (10Downward J. Parker P. Waterfield M.D. Nature. 1984; 311: 483-485Crossref PubMed Scopus (470) Google Scholar, 11Margolis B.L. Lax I. Kris R. Dombalagian M. Honegger A.M. Howk R. Givol D. Ullrich A. Schlessinger J. J. Biol. Chem. 1989; 264: 10667-10671Abstract Full Text PDF PubMed Google Scholar, 12Walton G.M. Chen W.S. Rosenfeld M.G. Gill G.N. J. Biol. Chem. 1990; 265: 1750-1754Abstract Full Text PDF PubMed Google Scholar). Furthermore, the EGFR is subject to regulation by other kinases. Hence, protein kinase C (PKC) phosphorylates the EGFR at Thr-654, thereby decreasing the intrinsic tyrosine kinase activity of the EGFR (13Hunter T. Ling N. Cooper J.A. Nature. 1984; 311: 480-483Crossref PubMed Scopus (422) Google Scholar, 14Davis R.J. J. Biol. Chem. 1988; 263: 9462-9469Abstract Full Text PDF PubMed Google Scholar). Phosphorylation of Ser-1002 by p34 cdc2 (15Kuppuswamy D. Dalton M. Pike L.J. J. Biol. Chem. 1993; 268: 19134-19242Abstract Full Text PDF PubMed Google Scholar) and of Ser-1046/1047 on the EGFR by calmodulin-dependent kinase II (16Countaway J.L. Nairn A.C. Davis R.J. J. Biol. Chem. 1992; 267: 1129-1140Abstract Full Text PDF PubMed Google Scholar) is likewise associated with inhibition of tyrosine kinase activity. The EGFR can also be phosphorylated on Thr-669 by mitogen-associated protein kinase (MAPK; Refs. 17Northwood I.C. Gonzalez F.A. Wartmann M. Raden D.L. Davis R.J. J. Biol. Chem. 1991; 266: 15266-15276Abstract Full Text PDF PubMed Google Scholar and 18Takishima K. Griswold-Prenner I. Ingebritsen T. Rosner M.R. Proc. Natl. Acad. Sci. (U. S. A.). 1991; 88: 2520-2524Crossref PubMed Scopus (108) Google Scholar). In addition, in vivopp60c-src phosphorylates the EGFR on three tyrosines (Tyr-845, -891, and -820) that are not the autophosphorylation sites (19Sato K.-i. Sato Y. Aoto M. Fukami Y. Biochem. Biophys. Res. Commun. 1995; 215: 1078-1087Crossref PubMed Scopus (121) Google Scholar, 20Stover D.R. Becker M. Liebetanz J. Lydon N.B. J. Biol. Chem. 1995; 270: 15591-15597Abstract Full Text Full Text PDF PubMed Scopus (189) Google Scholar). These novel phosphotyrosines may provide docking sites for SH2 domain-containing proteins, which would explain the enhancement of the mitogenic response to EGF observed in pp60c-src-overexpressing cells (20Stover D.R. Becker M. Liebetanz J. Lydon N.B. J. Biol. Chem. 1995; 270: 15591-15597Abstract Full Text Full Text PDF PubMed Scopus (189) Google Scholar). Previous in vitro studies have shown that the EGFR is a substrate for phosphorylation by PKA (21Rackoff W.R. Rubin R.A. Earp H.S. Mol. Cell. Endocrinol. 1984; 34: 113-119Crossref PubMed Scopus (23) Google Scholar, 22Ghosh-Dastidar P. Fox C.F. J. Biol. Chem. 1984; 259: 3864-3869Abstract Full Text PDF PubMed Google Scholar). However, to date, the functional significance of the phosphorylation has not been described. Since we and others have previously shown that EGF can activate adenylyl cyclase and increase cAMP accumulation in several tissues (4Nair B.G. Rashed H.M. Patel T.B. Growth Factors. 1993; 8: 41-48Crossref PubMed Scopus (34) Google Scholar,23Nakagowa Y. Gammichia J. Purushotham K.R. Schneyer C.A. Humphreys-Beher M.G. Biochem. Pharmacol. 1991; 42: 2333-2340Crossref PubMed Scopus (29) Google Scholar, 24Budnik L.T. Mukhopadhyay A.K. J. Biol. Chem. 1991; 266: 13908-13913Abstract Full Text PDF PubMed Google Scholar, 25Stryjek-Kaminska D. Piiper A. Zeuzem S. Am. J. Physiol. 1995; 269: G676-G682PubMed Google Scholar), in the present study we have investigated the possibility that PKA may modulate EGFR tyrosine kinase activity. Our data show that phosphorylation of the EGFR by PKA on serine residues leads to decreased tyrosine kinase activity and diminished autophosphorylation of the EGFR both in vitro and in vivo. Using the procedures described previously (26Hubler L. Levanthal P.S. Bertics Biochem. J. 1992; Scopus Google Scholar) wild type EGFR was purified from the (26Hubler L. Levanthal P.S. Bertics Biochem. J. 1992; Scopus Google Scholar), the EGFR and EGFRΔ1022–1186 were purified from B82L cells transfected to express forms of the The in of the EGFR with EGF from an EGFR The catalytic subunit of PKA from heart was in a MES, and The various forms of purified EGFR EGFRΔ1022–1186, and EGFRKD (amino acids were with PKAc in of phosphorylation and EGF or for the at were by of and at for were on The for and and were to the proteins were from and to as described previously H. Sun H. Fulgham D. Bertics P. Patel T.B. J. Biol. Chem. 1996; 271: 6947-6951Abstract Full Text Full Text PDF PubMed Scopus (76) Google Scholar). This was by two decreasing the autophosphorylation of the EGFR. we the kinase negative form of the EGFR W.S. G.M. H.S. Gill G.N. Rosenfeld M.G. Cell. 1989; Full Text PDF PubMed Scopus Google Scholar). This receptor was phosphorylated as described In the the tyrosine kinase activity of the wild type EGFR was by with G.N. Bertics Growth and J. Scholar) for in the phosphorylation described that and were of to of PKAc and were to phosphorylate the EGFR as described the to the EGFR were and associated with the receptor was the of in the the of of receptor were B82L cells EGFRΔ1022–1186 G.M. Chen W.S. Rosenfeld M.G. Gill G.N. J. Biol. Chem. 1990; 265: 1750-1754Abstract Full Text PDF PubMed Google Scholar) and REF-52 cells were at a of and to for The cells were then and treated with for the of were in and the were at for of the proteins in the was with and with of to the of were The from was to protein the of protein were then to were as described previously H. Sun H. Fulgham D. Bertics P. Patel T.B. J. Biol. Chem. 1996; 271: 6947-6951Abstract Full Text Full Text PDF PubMed Scopus (76) Google Scholar). a or a at was EGFR, of cellular proteins were with EGFR that of proteins from REF-52 cells were on the were with B82L cells cells the form of the EGFR were treated with and for The EGFR was then from of of with as described (7Nair B.G. Patel T.B. Biochem. Pharmacol. 1993; 46: 1239-1245Crossref PubMed Scopus (35) Google Scholar). of proteins in the by was with to the The was with to that of EGFR were WT, EGFRΔ1022–1186, or EGFRKD was with the of PKAc in phosphorylation described for at II and of were and phosphorylation was to for at in a of The were with of the were five for in and B82L cells the WT or Δ1022–1186 forms of EGFR were in and The cells were with of to and on for with the was and was on for a were then three with of and in of binding was in the of of the EGFR, the of A. Van D. A. Ullrich A. Schlessinger J. J. 1988; PubMed Scopus Google Scholar) was binding of to cells as described the cells were at for and then with as described was and with and cells were with and at in of to the of Because EGF can increase cAMP accumulation in the heart and other tissues (4Nair B.G. Rashed H.M. Patel T.B. Growth Factors. 1993; 8: 41-48Crossref PubMed Scopus (34) Google Scholar, 5Nair B.G. Rashed H.M. Patel T.B. Biochem. J. 1989; 264: 563-571Crossref PubMed Scopus (48) Google Scholar, 6Nair B.G. Parikh B. Milligan G. Patel T.B. J. Biol. Chem. 1990; 265: 21317-21322Abstract Full Text PDF PubMed Google Scholar, Y. Gammichia J. Purushotham K.R. Schneyer C.A. Humphreys-Beher M.G. Biochem. Pharmacol. 1991; 42: 2333-2340Crossref PubMed Scopus (29) Google Scholar, 24Budnik L.T. Mukhopadhyay A.K. J. Biol. Chem. 1991; 266: 13908-13913Abstract Full Text PDF PubMed Google Scholar, 25Stryjek-Kaminska D. Piiper A. Zeuzem S. Am. J. Physiol. 1995; 269: G676-G682PubMed Google Scholar), we that to the negative regulation of the EGFR by protein kinase C R.J. J. Biol. Chem. 1988; 263: 9462-9469Abstract Full Text PDF PubMed Google Scholar), calmodulin-dependent protein kinase II (16Countaway J.L. Nairn A.C. Davis R.J. J. Biol. Chem. 1992; 267: 1129-1140Abstract Full Text PDF PubMed Google Scholar) and p34 cdc2 (15Kuppuswamy D. Dalton M. Pike L.J. J. Biol. Chem. 1993; 268: 19134-19242Abstract Full Text PDF PubMed Google Scholar), PKA may the functional activity of EGFR. we the effect of PKAc on autophosphorylation of the purified WT and Δ1022–1186 forms of in the Δ1022–1186 form of EGFR, of the five autophosphorylation sites are A that PKAc decreases the of from the in the of Similar decreases were the WT-EGFR was with the PKA by This is in with the results of (21Rackoff W.R. Rubin R.A. Earp H.S. Mol. Cell. Endocrinol. 1984; 34: 113-119Crossref PubMed Scopus (23) Google Scholar) and P. Fox C.F. J. Biol. Chem. 1984; 259: 3864-3869Abstract Full Text PDF PubMed Google Scholar) an increase from the purified EGFR after of for are as (21Rackoff W.R. Rubin R.A. Earp H.S. Mol. Cell. Endocrinol. 1984; 34: 113-119Crossref PubMed Scopus (23) Google Scholar) the EGFR with PKA for which may be to phosphorylation of the EGFR on tyrosine and residues. in the of (21Rackoff W.R. Rubin R.A. Earp H.S. Mol. Cell. Endocrinol. 1984; 34: 113-119Crossref PubMed Scopus (23) Google Scholar) and and Fox P. Fox C.F. J. Biol. Chem. 1984; 259: 3864-3869Abstract Full Text PDF PubMed Google Scholar), an of was tyrosine which may with the EGFR, would tyrosine phosphorylation of the EGFR, thereby the increase in phosphorylation to be In in that a and the phosphorylation observed with would the of tyrosine and phosphorylation of the EGFR. Therefore, to PKAc altered tyrosine phosphorylation of the EGFR, to in A were with The were then to and with demonstrated by data in of the WT-EGFR with PKAc decreased tyrosine phosphorylation of the autophosphorylation of the Δ1022–1186 form of the EGFR was also decreased in the of Thus, the in in WT-EGFR observed in the of PKAc a in autophosphorylation of the tyrosine phosphorylation of the on the EGFRΔ1022–1186 is decreased in the of a serine or phosphorylation of receptor by PKAc, in would be phosphorylation of serine or by PKAc on EGFRΔ1022–1186 would for the of phosphorylation at PKAc phosphorylates serine or residues on the EGFR, were A that phosphorylation of the WT-EGFR on serine as also by (21Rackoff W.R. Rubin R.A. Earp H.S. Mol. Cell. Endocrinol. 1984; 34: 113-119Crossref PubMed Scopus (23) Google Scholar) and and Fox P. Fox C.F. J. Biol. Chem. 1984; 259: 3864-3869Abstract Full Text PDF PubMed Google Scholar). Furthermore, A that the of in the of PKAc is accompanied by a in PKAc also phosphorylates EGFRΔ1022–1186 on serine residues and increase in serine phosphorylation is accompanied by the of tyrosine These data the that, in with EGFRΔ1022–1186 and the receptor is observed in the of PKAc of a of serine phosphorylation and of tyrosine Because both the WT and EGFRΔ1022–1186 are phosphorylated on serine residues by PKAc, the data in that the PKAc phosphorylation not located in the region amino acids and In we the cytosolic region of the EGFR (amino acids is also phosphorylated by demonstrated by data in phosphorylation of the purified EGFRKD by PKAc resulted in a of the EGFRKD on polyacrylamide These data with the with the wild type and Δ1022–1186 forms of the EGFR and that the serine on the EGFR, which phosphorylated by PKAc, amino acids and phosphorylates the purified cytosolic domain of the EGFR EGFRKD and stoichiometrically phosphorylates the kinase negative (K721M) form of the EGFR and kinase WT-EGFR. cytosolic domain of the EGFR was in the of PKAc as described and were to and by The phosphorylation of EGFRKD by PKAc its by on the gel as for A of three is purified EGFR was in the of PKAc and for at in the described and The were by the of were by and to The to EGFR in the and of PKAc were and for A of three is of phosphorylation was of of purified EGFR was for as described and PKAc was then to the all of the phosphorylation were after and proteins by was to the The EGFR was from the and was by of phosphorylation was of of EGFR. that PKAc is on the Because the wild type EGFR is phosphorylated both on as well as Ser residues in the of PKAc, and tyrosine phosphorylation of the receptor decreases in the of PKAc the of phosphorylation was to we two phosphorylation of the kinase negative form of the EGFR was the WT-EGFR was to its tyrosine kinase activity G.N. Bertics Growth and J. Scholar). the phosphorylation was demonstrated in and autophosphorylation of the form of the EGFR or the wild type receptor in the of was PKAc phosphorylated both the kinase negative EGFR and WT-EGFR with a of and of of EGFR, Because of the WT and Δ1022–1186 forms of EGFR in the of PKAc decreased tyrosine phosphorylation of both receptors and would that phosphorylation of EGFR on serine residues the tyrosine kinase activity of the EGFR. Therefore, to the functional significance of phosphorylation of EGFR by PKAc, we the of PKAc on the tyrosine kinase activity of the WT and Δ1022–1186 forms of EGFR. that PKAc, in a tyrosine kinase activity of both of EGFR. Moreover, as demonstrated in PKAc also the tyrosine kinase activity of the the data in that the serine phosphorylation of the EGFR by PKAc is accompanied by a in tyrosine kinase activity of the Moreover, the of serine phosphorylation on the EGFR is located residues we investigated or not activation of PKA in EGF-induced tyrosine phosphorylation of cellular proteins and activation of the EGFR. cells were with 8-CPT-cAMP, a nonhydrolyzable cAMP analog, that activates PKA S. 1995; PubMed Scopus Google Scholar). that in REF-52 in the of 8-CPT-cAMP, the of EGF resulted in a increase in tyrosine phosphorylation of cellular The tyrosine phosphorylation in response to EGF was observed in proteins of of and of REF-52 cells with resulted in a in EGF-elicited tyrosine phosphorylation of proteins The in tyrosine phosphorylation of cellular proteins in the of be to in protein the with that the of PKAc in was the of Moreover, as with the EGFR EGF-elicited activation of the EGFR in REF-52 cells was also in the of of the EGFR from REF-52 cells treated with also a in EGF-elicited autophosphorylation of the EGFR in B82L cells transfected to express EGFRΔ1022–1186, activation of PKA by for also to a in tyrosine phosphorylation of proteins Thus, after of cells with 8-CPT-cAMP, a in tyrosine phosphorylation of cellular proteins was observed of cells with which activates adenylyl cyclase and increases cAMP G. Biochem. PubMed Scopus Google Scholar), results or not activation of PKA in intact cells phosphorylates the EGFR on serine the in C was B82L cells transfected to express the form of the EGFR were treated with for in the of the cells were and EGFR was of proteins in the with was shown in of cells with resulted in serine phosphorylation of the the of receptor from cells treated with and was the The data in that activation of PKA in intact cells results in serine phosphorylation of the EGFR, decreased activation of the receptor and decreased phosphorylation of cellular proteins in response to Moreover, the data in that activation of PKA in intact cells can phosphorylate the EGFR on serine residues in the of Thus, the EGFR not have to be by its for phosphorylation by for a in autophosphorylation of EGFR in intact cells in the of the PKA is that phosphorylation of the EGFR may binding of EGF to its receptor or receptor thereby decreasing the of EGF we the binding of and of the in B82L cells EGFRΔ1022–1186 that been with or These were with of of EGFR for EGF, in binding would be at of the data demonstrated that, in B82L cells EGFRΔ1022–1186, the binding of EGF was not altered of B82L cells EGFRΔ1022–1186 with not receptor These data that the in EGF-elicited receptor autophosphorylation observed in cells with is not the result of a in EGF binding to its receptors or a in EGFR of receptor internalization. Thus, the effects of PKA activation in intact cells the in vitro which that PKA, by EGFR on serine decreases its kinase of PKA in intact cells not binding of EGF or of the EGF cells cells the Δ1022–1186 form of the EGF receptor were The cells were then treated with and cAMP analog, for the binding of to the cells was as described and The of three are In a of the of the to the cells was as described and The of three are in a B82L cells cells the Δ1022–1186 form of the EGF receptor were The cells were then treated with and cAMP analog, for the binding of to the cells was as described and The of three are In a of the of the to the cells was as described and The of three are of EGFR tyrosine kinase activity by phosphorylation has been described for (13Hunter T. Ling N. Cooper J.A. Nature. 1984; 311: 480-483Crossref PubMed Scopus (422) Google Scholar, 14Davis R.J. J. Biol. Chem. 1988; 263: 9462-9469Abstract Full Text PDF PubMed Google Scholar), calmodulin-dependent protein kinase II (16Countaway J.L. Nairn A.C. Davis R.J. J. Biol. Chem. 1992; 267: 1129-1140Abstract Full Text PDF PubMed Google Scholar), and p34 cdc2 (15Kuppuswamy D. Dalton M. Pike L.J. J. Biol. Chem. 1993; 268: 19134-19242Abstract Full Text PDF PubMed Google Scholar). In all of phosphorylation decreases tyrosine kinase activity. Our data to the of protein that EGFR for the an effect of PKA on the of the EGF both in in date, studies of the of the on EGFR have on of on Thus, is that activation of the can have 1993; PubMed Scopus Google Scholar, J. P. T. A. 1992; Scopus Google Scholar, Proc. Natl. Acad. Sci. (U. S. A.). 1993; PubMed Scopus Google Scholar), M. P. Van J. Biol. Chem. 1994; 269: Full Text PDF PubMed Google Scholar), or J. Biol. Chem. 1995; 270: Full Text Full Text PDF PubMed Scopus Google Scholar) effects on the activation of by EGF, on the type This is of the various in the P. J. Cooper G.M. Mol. Biol. 1995; PubMed Scopus (121) Google Scholar). However, studies in which intracellular cAMP were to modulate activation in response to EGF to show an effect on WT-EGFR autophosphorylation 1993; PubMed Scopus Google Scholar, J. P. T. A. 1992; Scopus Google Scholar, P. J.L. J. 1993; PubMed Scopus Google Scholar, M.D. N. D. 1996; Full Text PDF PubMed Scopus Google Scholar). This is in with data which that PKA can with the EGFR at the of the EGFR for may be that the the which were used in a of the studies may not be for effect of PKA the of EGFR the of in B82L cells that the we have also not observed in EGF-elicited tyrosine phosphorylation of cellular proteins in the of In with of others 1993; PubMed Scopus Google Scholar, J. P. T. A. 1992; Scopus Google Scholar, Proc. Natl. Acad. Sci. (U. S. A.). 1993; PubMed Scopus Google Scholar) that, in some PKA can activation of by both the EGFR kinase as well as of and and two may in a the EGFR is not the receptor tyrosine kinase for regulation by Hence, of cells with increases phosphorylation of the receptor and decreases its tyrosine kinase activity by L. J. Biol. Chem. Full Text PDF PubMed Google Scholar). This in receptor tyrosine kinase activity by has been vitro which demonstrated that PKA phosphorylates the receptor and decreases its tyrosine kinase activity R.A. J. PubMed Scopus Google Scholar). These with would that PKA may a in regulation of receptor kinase at the of the serine on EGFR which phosphorylated are some sites that can be Thus, PKA phosphorylates and the activity of the EGFR and cytosolic domain of the receptor would that the serine which phosphorylated and EGFR kinase activity in the cytosolic amino acids and region of the EGFR, serine residues and have been shown to be phosphorylated (15Kuppuswamy D. Dalton M. Pike L.J. J. Biol. Chem. 1993; 268: 19134-19242Abstract Full Text PDF PubMed Google Scholar, Gill G.N. J. Biol. Chem. 1988; 263: Full Text PDF PubMed Google Scholar). the phosphorylation of Ser-1002 by p34 cdc2 has been shown to EGFR tyrosine kinase activity (15Kuppuswamy D. Dalton M. Pike L.J. J. Biol. Chem. 1993; 268: 19134-19242Abstract Full Text PDF PubMed Google Scholar). The functional significance of phosphorylation of and to be Gill G.N. J. Biol. Chem. 1988; 263: Full Text PDF PubMed Google Scholar). of sites Ser-1002 to the PKA the of the serine residues on EGFR that are phosphorylated by PKA and that EGFR kinase activity forms the subject of In we have demonstrated that PKA can phosphorylate EGFR on serine and that phosphorylation is accompanied by a in EGFR kinase activity both in vitro and in vivo. In of that EGFR kinase activity is to adenylyl cyclase activity (7Nair B.G. Patel T.B. Biochem. Pharmacol. 1993; 46: 1239-1245Crossref PubMed Scopus (35) Google Scholar) and increase intracellular cAMP B.G. Rashed H.M. Patel T.B. Biochem. J. 1989; 264: 563-571Crossref PubMed Scopus (48) Google Scholar), the would that activation of PKA in a regulatory EGFR tyrosine kinase activity. are to N. of for with the purified cytosolic region of the EGFR (EGFRKD).

References

37